Literature DB >> 11396537

Defining gluten refractory enteropathy.

F Biagi1, G R Corazza.   

Abstract

OBJECTIVE: The diagnosis of coeliac disease (CD) is based on the responsiveness of the enteropathy to a gluten-free diet (GFD). This implies that terms such as 'non-responsive CD' and 'refractory CD' are almost paradoxical. In spite of this, these terms are commonly used in the literature, often with different and confusing meanings.
METHODS: On the basis of both a review of the literature and our clinical experience, we propose the following classification. A condition characterized by a refractory enteropathy, not due to lymphoma, ulcerative jejunoileitis or collagenous sprue, but in which gluten sensitivity has been shown previously or could be shown while the patients were on an immunosuppressive therapy should be indicated as refractory CD. Those patients in whom gluten sensitivity can be excluded should be considered to be affected by non-coeliac refractory sprue. Finally, patients in whom the presence of CD cannot be either confirmed or excluded should be considered to be affected by undefined sprue.
RESULTS: Twenty-four certain refractory patients are described in the literature. The data suggest a diagnosis of refractory CD in 13 patients, non-coeliac refractory sprue in three patients, and undefined sprue in eight patients.
CONCLUSIONS: We define refractory CD as a form of CD that no longer responds to a GFD. Non-coeliac refractory sprue is a condition unrelated to CD. It could be either an independent condition or a common end point of different enteropathies.

Entities:  

Mesh:

Year:  2001        PMID: 11396537     DOI: 10.1097/00042737-200105000-00016

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  21 in total

Review 1.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

Review 2.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

3.  Collagenous sprue: a case report and literature review.

Authors:  Zuoliang Xiao; Vijaya M Dasari; Donald F Kirby; Mary Bronner; Thomas P Plesec; Bret A Lashner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

4.  Capsule endoscopy in nonresponsive celiac disease.

Authors:  David S Atlas; Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Joseph A Murray
Journal:  Gastrointest Endosc       Date:  2011-08-11       Impact factor: 9.427

Review 5.  Mortality in celiac disease.

Authors:  Federico Biagi; Gino R Corazza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02-02       Impact factor: 46.802

Review 6.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

7.  Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry.

Authors:  A Rubio-Tapia; G Malamut; W H M Verbeek; R L J van Wanrooij; D A Leffler; S I Niveloni; C Arguelles-Grande; B D Lahr; A R Zinsmeister; J A Murray; C P Kelly; J C Bai; P H Green; S Daum; C J J Mulder; C Cellier
Journal:  Aliment Pharmacol Ther       Date:  2016-08-03       Impact factor: 8.171

8.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

9.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

10.  Clinical staging and survival in refractory celiac disease: a single center experience.

Authors:  Alberto Rubio-Tapia; Darlene G Kelly; Brian D Lahr; Ahmet Dogan; Tsung-Teh Wu; Joseph A Murray
Journal:  Gastroenterology       Date:  2008-10-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.